References
- Lotan R. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res 1996; 16: 2415–2419
- Muindi J. R. Retinoids in clinical cancer therapy. Cancer Treat Res 1996; 87: 305–342
- Kurie J. M., Lee J. S., Griffin T., Lippman S. ML, Drum P., Thomas M. P., Weber C., Bader M., Massimini G., Hong W. K. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996; 2: 287–293
- Miller W. H., Jr., Jakubowski A., Tong W. P., Miller V. A., Rigas J. R., Benedetti F., Gill G. M., Truglia J. A., Ulm E., Shirley M., Warrell R. P. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 1995; 85: 3021–3027
- Warrell R. P., Jr., De The H., Wang Z. Y., Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177–189
- Fenaux P., Chomienne C. Biology and treatment of acute promyelocytic leukemia. Curr Opin Oncol 1996; 8: 3–12
- Tallman M. S., Andersen J. W., Schiffer C. A., Appelbaum F. R., Feusner J. H., Ogden A., Shepherd L., Willman C., Bloomfield C. D., Rowe J. M., Wiernik P. H. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021–1028
- Kessler J. F., Meyskens F. L., Levine N., Lynch P. J., Jones S. E. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet 1983; 1: 1345–1347
- Cheng A. L., Su I. J., Chen C. C., Tien H. F., Lay J. D., Chen B. R., Pu Y. S., Hong R. L., Shen M. C., Wang C. H. Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J Clin Oncol 1994; 12: 1185–1192
- Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
- Miller V. A., Rigas J. R., Benedetti F. M., Verret A. L., Tong W. P., Kris M. G., Gill G. M., Loewen G. R., Truglia J. A., Ulm E. H., Warrell R. P. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996; 2: 471–475
- Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J. C., Pierotti M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphe-nyl) retinamide and effect of deregulated bcl-2. Blood 1995; 85: 359–67
- Shalinsky D. R., Bischoff E. D., Gregory M. L., Lamph W. W., Heyman R. A., Hayes J. S., Thomazy V., Davies P. J. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res 1996; 2: 511–520